glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma Frontiers | Successes and challenges

Frontiers Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms glutathione gbm6 patient derived xenograft Methionine cycle inhibition disrupts antioxidant metabolism and reduces glioblastoma cell survival Combined inhibition of de novo Patient Derived Glioma Models: From Patients to Dish to Animals Frontiers Clinically relevant glioblastoma patient derived xenograft models to guide drug development and identify molecular signatures Catabolism of extracellular glutathione supplies cysteine to support tumours Nature CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia induced invasion, and therapeutic resistance bioRxiv

SKU: 92577203578 · From condeoeiras.edu.pt